Page last updated: 2024-11-03

resorcinol and Obesity

resorcinol has been researched along with Obesity in 1 studies

resorcinol: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7951
resorcinol : A benzenediol that is benzene dihydroxylated at positions 1 and 3.

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Riis, PT1
Saunte, DM1
Sigsgaard, V1
Villani, AP1
Guillem, P1
Pascual, JC1
Kappe, NN1
Vanlaerhoven, AMJD1
van der Zee, HH1
Prens, EP1
El-Domyati, M1
Abdel-Wahab, H1
Moftah, N1
Abdelghani, R1
Agut-Busquet, E1
Romaní, J1
Hlela, C1
van den Worm, L1
Bettoli, V1
Calamo, G1
Gürer, MA1
Beksaç, B1
Matusiak, L1
Glowaczewska, A1
Szepietowski, JC1
Emtestam, L1
Lapins, J1
Kottb, HR1
Fatani, M1
Weibel, L1
Theiler, M1
Delage-Toriel, M1
Lam, TTH1
Nassif, A1
Becherel, PA1
Dolenc-Voljc, M1
Doss, N1
Bouazzi, D1
Benhadou, F1
Del Marmol, V1
Jemec, GBE1

Other Studies

1 other study available for resorcinol and Obesity

ArticleYear
Clinical characteristics of pediatric hidradenitis suppurativa: a cross-sectional multicenter study of 140 patients.
    Archives of dermatological research, 2020, Volume: 312, Issue:10

    Topics: Acne Vulgaris; Administration, Cutaneous; Administration, Oral; Adolescent; Anti-Bacterial Agents; B

2020